<DOC>
	<DOC>NCT02302690</DOC>
	<brief_summary>The proposed research protocol aims at addressing these points by pre-screening CN patients for their AAV serology in link with their medical history and current medical status. A first objective is to assess the presence of neutralizing AAV antibodies in the serum of CN patients.</brief_summary>
	<brief_title>Immunity Against AAV in Crigler Najjar Patient</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Crigler-Najjar Syndrome</mesh_term>
	<criteria>The patient has a CriglerNajjar syndrome The molecular diagnosis has been confirmed by UGT1A1 gene DNA sequencing Exclusion criteria: The patient is liver transplanted The patient is suffering from severe associated pathologies precluding further enrolment in a future interventional clinical study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>